Literature DB >> 15062519

The evaluation and management of patients with neuroleptic malignant syndrome.

Minal J Bhanushali1, Paul J Tuite.   

Abstract

NMS is a rare but fatal syndrome that needs to be considered in the perioperative period. Although many aspects remain unexplored and controversial, with greater awareness of the condition, new concepts are coming into light. Definitive treatment guidelines remain an important issue to be addressed. Efforts have been initiated in that direction and all cases can be reported on a toll-free hotline ( 1-888-667-8367) or online (www.nmsis.org).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15062519     DOI: 10.1016/j.ncl.2003.12.006

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  14 in total

1.  Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.

Authors:  Eric Brantley; Jamieson Cohn; Kavita Babu
Journal:  J Med Toxicol       Date:  2009-06

2.  Soft diagnosis, guidelines and hard choices.

Authors:  Karol Antczak; Elizabeth Cummings
Journal:  BJPsych Bull       Date:  2017-12

3.  An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome.

Authors:  Roland van Rensburg; Eric H Decloedt
Journal:  Psychopharmacol Bull       Date:  2019-02-15

4.  Neuroleptic malignant syndrome: a review for neurohospitalists.

Authors:  Brian D Berman
Journal:  Neurohospitalist       Date:  2011-01

Review 5.  The hot patient: acute drug-induced hyperthermia.

Authors:  Nazila Jamshidi; Andrew Dawson
Journal:  Aust Prescr       Date:  2019-02-01

6.  Neuroleptic malignant syndrome and closed head injury: A case report and review.

Authors:  Nissar Shaikh; Ghanem Al-Sulaiti; Abdel Nasser; Muhammad Ataur Rahman
Journal:  Asian J Neurosurg       Date:  2011-07

7.  Neuroleptic Malignant Syndrome: A Case Aimed at Raising Clinical Awareness.

Authors:  Jad Al Danaf; John Madara; Caitlin Dietsche
Journal:  Case Rep Med       Date:  2015-06-11

8.  Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission.

Authors:  Faizan Mazhar; Shahzad Akram; Nafis Haider; Rafeeque Ahmed
Journal:  Case Rep Med       Date:  2016-06-28

Review 9.  Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report.

Authors:  Julie Langan; Daniel Martin; Polash Shajahan; Daniel J Smith
Journal:  BMC Psychiatry       Date:  2012-11-29       Impact factor: 3.630

10.  Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia.

Authors:  Philip E Lee; Sudeep S Gill; Paula Rochon
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.